AVP-786 for the treatment of agitation in dementia of the Alzheimer's type (Q39034436)

8 September 2017

1 reference

title

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type (English)

1 reference

8 September 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

George T Grossberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

11 December 2016

1 reference

Expert Opinion on Investigational Drugs

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

121-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

Systematic review of recent dementia practice guidelines

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The burden of health care costs for patients with dementia in the last 5 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Investigational drugs for treating agitation in persons with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Advancements in the treatment of agitation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Isn't Your Staff Trained To Manage My Mother?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Nonpharmacologic management of behavioral symptoms in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

An autoradiographic study of dextromethorphan high-affinity binding sites in rat brain: sodium-dependency and colocalization with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Phencyclidine receptors in rat brain cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

A 96-well filtration method for radioligand binding analysis of σ receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Characterization of [3H]nisoxetine binding in rat vas deferens membranes: Modulation by sigma and PCP ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Antitussive activity of sigma-1 receptor agonists in the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Central regulation of the cough reflex: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Subsensitivity to the cough-depressant effects of opioid and nonopioid antitussives in morphine-dependent rats: relationship to central serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

( )-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Neuropsychotoxic and Neuroprotective Potentials of Dextromethorphan and Its Analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The Effect of the N-methyl-D-aspartate Receptor Antagonist Dextromethorphan on Perioperative Brain Injury in Children Undergoing Cardiac Surgery with Cardiopulmonary Bypass: Results of a Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

21 January 2018

Quinine and quinidine

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Molecular genetics of the debrisoquin-sparteine polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Dextromethorphan. An overview of safety issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Deuterated drugs draw heavier backing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

The Polymorphic Metabolism of Dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13543784.2017.1267726

10.1080/13543784.2017.1267726

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27936965 AND SRC:MED&resulttype=core&format=json

7 June 2020

1 reference